<!DOCTYPE html>
<html lang="tr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="color-scheme" content="light">
    <meta name="site-base" content="/">
    <link rel="stylesheet" href="/assets/theme.css">
    <script defer src="/assets/theme.js"></script>
    <title>Kılavuzlar</title>
</head>
<body data-base="/">
<article id="07f20785-9ae8-4d3d-befb-25f654db3c79" class="page sans"><header><h1 class="page-title">Kılavuzlar</h1><p class="page-description"></p></header><div class="page-body"><h1 id="d6010c3e-7d3b-47b5-abba-8d6085a7f282" class="">HPLC Yöntem Validasyonu: Referanslar Listesi</h1><p id="127b6792-444f-8064-b0e5-faf83491b230" class="">
</p><p id="127b6792-444f-8093-8aef-ce0e92fa3443" class="">Not: Tüm referanslar için en güncel versiyonları kontrol etmek önemlidir, çünkü rehberler ve standartlar zaman zaman güncellenmektedir. Ayrıca, bazı kaynaklar abonelik veya satın alma gerektirebilir.</p><h2 id="20339f91-fdcf-4d1c-a121-eb14cebfa40d" class="">Uluslararası Kılavuzlar</h2><ol type="1" id="66a107d6-7371-423e-a9cd-7a7bf0e46af1" class="numbered-list" start="1"><li>ICH Q2(R1) (2005). Validation of Analytical Procedures: Text and Methodology.<br/><a href="https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf">https://database.ich.org/sites/default/files/Q2(R1) Guideline.pdf</a><figure id="e1a42ce9-04d2-4c42-89a2-7d006dac3a79"><div class="source"><a href="guidelines/q2-r1.pdf">Q2(R1) Guideline.pdf</a></div></figure></li></ol><ol type="1" id="f0c3e11a-c610-4ce4-9193-ce1109648ec3" class="numbered-list" start="2"><li>ICH Q7 (2000). Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.<br/><a href="https://database.ich.org/sites/default/files/Q7%20Guideline.pdf">https://database.ich.org/sites/default/files/Q7 Guideline.pdf</a><figure id="83f40dd4-2742-4760-8ac9-ce28f22211ee"><div class="source"><a href="guidelines/q7.pdf">Q7 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="bc0557a1-d36b-434c-b3fc-5ab8589b4b03" class="numbered-list" start="3"><li>ICH Q8(R2) (2009). Pharmaceutical Development.<br/><a href="https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf">https://database.ich.org/sites/default/files/Q8(R2) Guideline.pdf</a><figure id="9f7dcfda-6e52-49ab-bc5b-e9d115aa3130"><div class="source"><a href="guidelines/q8-r2.pdf">Q8(R2) Guideline.pdf</a></div></figure></li></ol><ol type="1" id="358bfa81-c971-4932-885b-96d6d14ce570" class="numbered-list" start="4"><li>ICH Q9 (2005). Quality Risk Management.<br/><a href="https://database.ich.org/sites/default/files/Q9%20Guideline.pdf">https://database.ich.org/sites/default/files/Q9 Guideline.pdf</a><figure id="3bb61047-25a0-4d8f-947a-0450a7fa8e81"><div class="source"><a href="guidelines/q9.pdf">Q9 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="683c865e-3a83-4179-bb50-a3e735a4455e" class="numbered-list" start="5"><li>ICH Q10 (2008). Pharmaceutical Quality System.<br/><a href="https://database.ich.org/sites/default/files/Q10%20Guideline.pdf">https://database.ich.org/sites/default/files/Q10 Guideline.pdf</a><figure id="24ff48f3-93c1-42b6-b0c4-5ef216e0a09a"><div class="source"><a href="guidelines/q10.pdf">Q10 Guideline.pdf</a></div></figure></li></ol><ol type="1" id="33587755-0db2-4cf0-ba2f-8adbc7df3c14" class="numbered-list" start="6"><li>ICH Q11 (2012). Development and Manufacture of Drug Substances.<br/><a href="https://database.ich.org/sites/default/files/Q11%20Guideline.pdf">https://database.ich.org/sites/default/files/Q11 Guideline.pdf</a><figure id="dcef1b15-34a2-4082-adff-b3c43d8e2d73"><div class="source"><a href="guidelines/q11.pdf">Q11 Guideline.pdf</a></div></figure></li></ol><h2 id="fc2f45a7-c1a7-43f9-bb3f-fcedc94ebbd9" class="">Farmakopeler</h2><ol type="1" id="004504e0-d2c8-4d4b-8348-82ad02fcdf93" class="numbered-list" start="1"><li>United States Pharmacopeia (USP) &lt;1225&gt;: Validation of Compendial Procedures.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.usp.org/">https://www.usp.org/</a>)</li></ol><ol type="1" id="e655d7f4-f779-420b-aeda-6f7d08e06160" class="numbered-list" start="2"><li>European Pharmacopoeia (EP) 2.2.46: Chromatographic Separation Techniques.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition">https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition</a>)</li></ol><ol type="1" id="b0f48dc8-7dc7-479e-b1aa-9a04d968d085" class="numbered-list" start="3"><li>Japanese Pharmacopoeia (JP) G1: Validation of Analytical Procedures.<br/>(En güncel versiyonu kontrol edin: <a href="https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066530.html">https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066530.html</a>)</li></ol><h2 id="9069d824-fe51-4b56-bfca-dde4b5105319" class="">FDA Rehberleri</h2><ol type="1" id="f4063ab9-b97c-4cbf-b424-7f0c4853cc1a" class="numbered-list" start="1"><li>FDA (2015). Analytical Procedures and Methods Validation for Drugs and Biologics: Guidance for Industry.<br/><a href="https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf">https://www.fda.gov/files/drugs/published/Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf</a><figure id="d24e53a7-de15-4b4c-a820-0fb206ff2205"><div class="source"><a href="guidelines/analytical-procedures-validation.pdf">Analytical-Procedures-and-Methods-Validation-for-Drugs-and-Biologics.pdf</a></div></figure></li></ol><ol type="1" id="3a136c8c-ec53-4629-b30c-07ba83954ef1" class="numbered-list" start="2"><li>FDA (2018). Data Integrity and Compliance With Drug CGMP: Questions and Answers Guidance for Industry.<br/><a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers-guidance-industry">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers-guidance-industry</a><figure id="0fbb6792-444f-80c0-81e9-eb6628e2b1a9"><div class="source"><a href="guidelines/data-integrity.pdf">Data Integrity and Compliance.pdf</a></div></figure></li></ol><ol type="1" id="05a72785-0d1f-494d-929b-485ce1e4a1d5" class="numbered-list" start="3"><li>FDA (2003). Part 11, Electronic Records; Electronic Signatures - Scope and Application.<br/><a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application</a><figure id="4bd1c748-831e-4615-b1ea-4ca307b2f78b"><div class="source"><a href="guidelines/guidance-for-industry.pdf">Guidance for Industry.pdf</a></div></figure></li></ol><h2 id="e3742018-d786-41c4-ae2b-5f03a804d2b7" class="">EMA Rehberleri</h2><ol type="1" id="6fa7bdf5-fd25-4eb2-bd6a-50b74220b0fc" class="numbered-list" start="1"><li>EMA (2011). Guideline on bioanalytical method validation.<br/><a href="https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf">https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf</a><figure id="75b55cad-f371-4bbf-9aa9-f7dec819cec4"><div class="source"><a href="guidelines/bioanalytical-method-validation.pdf">guideline-bioanalytical-method-validation_en.pdf</a></div></figure></li></ol><ol type="1" id="71246877-9def-4d35-a4b4-f15319dade18" class="numbered-list" start="2"><li>EudraLex Volume 4, Annex 11: Computerised Systems.<br/><a href="https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf">https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf</a><figure id="ce5165d3-f1b0-4bb6-b91f-839021250990"><div class="source"><a href="guidelines/eudralex-volume-4.pdf">EudraLex Volume 4.pdf</a></div></figure></li></ol><h2 id="2d232673-30a4-4c89-93f0-da0538d69f6f" class="">WHO Rehberleri</h2><ol type="1" id="e705638c-6a54-4027-aa06-a8910eab13f5" class="numbered-list" start="1"><li>WHO (2016). Guidance on Good Data and Record Management Practices.<br/><a href="https://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_annex05.pdf">https://www.who.int/medicines/publications/pharmprep/WHO_TRS_996_annex05.pdf</a><figure id="0bc88dc9-7c44-4713-94d6-155cc8e7b57f"><div class="source"><a href="guidelines/data-record-management.pdf">Guidance on good data and record management practices.pdf</a></div></figure></li></ol><h2 id="d1127844-2862-46c3-89df-5c430e14e62f" class="">Diğer Düzenleyici Otoritelerin Rehberleri</h2><ol type="1" id="d7953f80-4108-4042-b2c6-0099418705c0" class="numbered-list" start="1"><li>MHRA (2018). &#x27;GXP&#x27; Data Integrity Guidance and Definitions.<br/><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf</a></li></ol><ol type="1" id="a1fb325c-e3e0-4043-ba41-d8ee0b2ade30" class="numbered-list" start="2"><li>PIC/S (2021). Good Practices for Data Management and Integrity in Regulated GMP/GDP Environments.<br/><a href="https://picscheme.org/docview/4234">https://picscheme.org/docview/4234</a><figure id="dbceee3f-32d5-46e8-ac36-e90e9b295085"><div class="source"><a href="guidelines/data-management-good-practices.pdf">Good Practices for Data Management and Integrity in Regulated GMPGDP Environments.pdf</a></div></figure></li></ol><h2 id="9382e810-ee9d-432f-8ca9-ea10c60f8401" class="">Bilimsel Makaleler ve Kitaplar</h2><ol type="1" id="43f85cfa-0dbf-4301-8aae-8a377a3247a7" class="numbered-list" start="1"><li>Snyder, L.R., Kirkland, J.J., &amp; Dolan, J.W. (2010). Introduction to Modern Liquid Chromatography (3rd ed.). John Wiley &amp; Sons.<figure id="3db62176-929e-4d38-93e2-b5496b4365fe"><div class="source"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/687246/MHRA_GxP_data_integrity_guide_March_edited_Final.pdf">MHRA_GxP_data_integrity_guide_March_edited_Final.pdf</a></div></figure></li></ol><ol type="1" id="1da67afb-a887-480e-982d-38f86fec6efb" class="numbered-list" start="2"><li>Ermer, J., &amp; Miller, J.H.M. (Eds.). (2005). Method Validation in Pharmaceutical Analysis: A Guide to Best Practice. Wiley-VCH.<figure id="c86b1229-3242-4d4a-910d-f56c6f25f8c7"><div class="source"><a href="https://www.wellesu.com/10.1002/3527604685">Method Validation in Pharmaceutical Analysis</a></div></figure></li></ol><ol type="1" id="80a5c93d-91d9-463b-8fcc-1ed0c138901a" class="numbered-list" start="3"><li>habir, G.A. (2003). Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. Journal of Chromatography A, 987(1-2), 57-66.<figure id="1437ec59-fdba-4c62-90f1-befe027120a7"><div class="source"><a href="guidelines/hplc-validation-pharmaceutical.pdf">Validation of high-performance liquid chromatography methods for pharmaceutical analysis.pdf</a></div></figure></li></ol><p id="f1d85163-862c-4b9f-aa1a-4c2709e608c8" class="">
</p><p id="a7c02b46-fefa-4a80-83a3-4dd9d5132569" class="">
</p></div></article><span class="sans"></span>
</body>
</html>
